For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback